|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||86.50 / 106.67|
ELF Beauty is now officially a public company. Here is what the company's CEO has planned to keep the company's results looking sexy.
CVS Health (CVS) is putting its curbside delivery program on hold after the company's app was backlogged with orders, causing it to significantly slow down.
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.
Company announces new partnership with DoSomething.org through its foundation and renews successful Pharmacists Teach prevention program
Sales dropped 0.3% in August, the Census Bureau said this morning, dragged lower by automobiles. That's not good news for banks like JPMorgan Chase hoping for higher interest rates.
With more than one million patients enrolled at the retail pharmacy, the service now expands to mail service pharmacy
Nearly 40 CVS Pharmacy locations in Washington can now dispense naloxone
It doesn't seem a stretch to think CVS could rebound to $100 or better over the coming 12 months.
Greg Nathan, portfolio manager for the FPA U.S. Value Fund, is ignoring the clamor over drug pricing with these choices.
McKesson is down 10 percent year-to-date due to the heated political debate over drug pricing but the stock is too cheap to ignore.
$225,000 investment expands programming at twenty YMCA Chapters
Most of the portfolio got caught in this week's downdraft, though we used weakness to add to our position in Sherwin-Williams.
Here's a technical look at how to trade some of the biggest stocks on the market right now.
Free wellness events have delivered more than $112 million worth of health services over the past decade
Customers can support Stand Up To Cancer's groundbreaking cancer research with a donation at the register at CVS Pharmacy locations nationwide
We added no positions this week, although we scaled up our position sizes in both Costco Wholesale and United Parcel Service.
And how to play the fallout on related stocks.
Momentum indicators are down hard, so is relative strength, while earnings were great.
We eliminated our position in Fortive but bulked up our stakes in recent newbies Sherwin-Williams and Whirlpool and added Nike to the portfolio.
Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Sears should be embarrassed by the state of its New York City stores.
As Thursday's breakdown develops, CVS will face a very important test.
The retailer's recent price weakness is an opportunity for investors to act.
CVS stock is under pressure on Thursday after Mylan (MYL) said it would cut the cost of its EpiPen, which could hit the pharmacy's bottom line.
Investment assures families have access to Easterseals' early childhood services nationwide
Interventions focused on keeping patients adherent as well as those focused on patients with three or more chronic conditions can result in significant cost savings